Drug Type Cytokines |
Synonyms Pro 101-3, Pro101-3 |
Target |
Mechanism PDGFR agonists(Platelet-derived growth factor receptor agonists) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alopecia | Preclinical | CN | 13 May 2024 | |
Hemorrhoids | Preclinical | CN | 13 May 2024 | |
Photosensitivity Disorders | Preclinical | CN | 13 May 2024 |